Globus Medical Stock Price, News & Analysis (NYSE:GMED)

$47.91 -0.57 (-1.18 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$48.48
Today's Range$47.35 - $49.03
52-Week Range$26.95 - $50.88
Volume664,900 shs
Average Volume703,470 shs
Market Capitalization$4.63 billion
P/E Ratio43.55
Dividend YieldN/A
Beta0.48

About Globus Medical (NYSE:GMED)

Globus Medical logoGlobus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Receive GMED News and Ratings via Email

Sign-up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:GMED
CUSIP37957720
Phone610-930-1800

Debt

Debt-to-Equity RatioN/A
Current Ratio7.52%
Quick Ratio6.03%

Price-To-Earnings

Trailing P/E Ratio43.5549414085583
Forward P/E Ratio32.59
P/E Growth2.81

Sales & Book Value

Annual Sales$563.99 million
Price / Sales8.19
Cash Flow$1.67 per share
Price / Cash28.63
Book Value$8.67 per share
Price / Book5.53

Profitability

Trailing EPS$1.10
Net Income$104.34 million
Net Margins16.88%
Return on Equity14.18%
Return on Assets12.84%

Miscellaneous

Employees1,400
Outstanding Shares96,380,000

Globus Medical (NYSE:GMED) Frequently Asked Questions

What is Globus Medical's stock symbol?

Globus Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMED."

How were Globus Medical's earnings last quarter?

Globus Medical Inc (NYSE:GMED) posted its quarterly earnings results on Wednesday, February, 21st. The medical device company reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.35 by $0.03. The medical device company had revenue of $176.03 million for the quarter, compared to analyst estimates of $175.50 million. Globus Medical had a net margin of 16.88% and a return on equity of 14.18%. The firm's revenue for the quarter was up 16.1% on a year-over-year basis. During the same quarter last year, the business posted $0.31 EPS. View Globus Medical's Earnings History.

When will Globus Medical make its next earnings announcement?

Globus Medical is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for Globus Medical.

What guidance has Globus Medical issued on next quarter's earnings?

Globus Medical issued an update on its FY18 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of approx $1.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.50. The company issued revenue guidance of approx $690 million, compared to the consensus revenue estimate of $690.85 million.

Where is Globus Medical's stock going? Where will Globus Medical's stock price be in 2018?

12 brokers have issued 1-year target prices for Globus Medical's stock. Their forecasts range from $31.00 to $53.00. On average, they expect Globus Medical's stock price to reach $46.29 in the next year. View Analyst Ratings for Globus Medical.

What are Wall Street analysts saying about Globus Medical stock?

Here are some recent quotes from research analysts about Globus Medical stock:

  • 1. Needham & Company LLC analysts commented, "GMED’s 4Q17 revenue was consistent with its 1/9/18 preannouncement and its EPS beat consensus. Management reiterated 2018 revenue guidance of $690M and adjusted EPS guidance of $1.50. We estimate that the Emerging Technology segment drove much of the upside given the incremental revenue and negligible EPS drag. Gross margin was up 250 bps Y/Y and operating margin was up 60 bps Y/Y. We maintain our Hold rating since we believe that GMED’s valuation appropriately reflects its Emerging Technologies business’ potential." (2/22/2018)
  • 2. According to Zacks Investment Research, "Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. " (1/10/2018)

Who are some of Globus Medical's key competitors?

Who are Globus Medical's key executives?

Globus Medical's management team includes the folowing people:

  • David C. Paul, Executive Chairman of the Board (Age 50)
  • Anthony L. Williams, President (Age 46)
  • David M. Demski, Chief Executive Officer, Director (Age 59)
  • Daniel T. Scavilla, Chief Financial Officer, Senior Vice President (Age 52)
  • Andrew Brett Murphy, Group President, Commercial Operations (Age 52)
  • Kurt C. Wheeler, Lead Independent Director (Age 64)
  • David D. Davidar, Director (Age 51)
  • Daniel T. Lemaitre, Independent Director (Age 63)
  • Robert W. Liptak CPA, Independent Director (Age 53)
  • Ann D. Rhoads, Independent Director (Age 51)

Who owns Globus Medical stock?

Globus Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.09%), Bank of New York Mellon Corp (1.93%), Standard Life Aberdeen plc (1.79%), GW&K Investment Management LLC (1.34%), NWQ Investment Management Company LLC (1.29%) and AXA (0.96%). Company insiders that own Globus Medical stock include A Brett Murphy, Anthony L Williams, David D Davidar and Steven Payne. View Institutional Ownership Trends for Globus Medical.

Who sold Globus Medical stock? Who is selling Globus Medical stock?

Globus Medical's stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Nuance Investments LLC, The Manufacturers Life Insurance Company , Bank of New York Mellon Corp, Glenmede Trust Co. NA, Standard Life Aberdeen plc, Renaissance Technologies LLC and Rice Hall James & Associates LLC. Company insiders that have sold Globus Medical company stock in the last year include A Brett Murphy, Anthony L Williams, David D Davidar and Steven Payne. View Insider Buying and Selling for Globus Medical.

Who bought Globus Medical stock? Who is buying Globus Medical stock?

Globus Medical's stock was bought by a variety of institutional investors in the last quarter, including NWQ Investment Management Company LLC, Pembroke Management LTD, Redmile Group LLC, Guggenheim Capital LLC, APG Asset Management N.V., AXA, BlackRock Inc. and Perceptive Advisors LLC. View Insider Buying and Selling for Globus Medical.

How do I buy Globus Medical stock?

Shares of Globus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Globus Medical's stock price today?

One share of Globus Medical stock can currently be purchased for approximately $47.91.

How big of a company is Globus Medical?

Globus Medical has a market capitalization of $4.63 billion and generates $563.99 million in revenue each year. The medical device company earns $104.34 million in net income (profit) each year or $1.10 on an earnings per share basis. Globus Medical employs 1,400 workers across the globe.

How can I contact Globus Medical?

Globus Medical's mailing address is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. The medical device company can be reached via phone at 610-930-1800 or via email at [email protected]


MarketBeat Community Rating for Globus Medical (GMED)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  330 (Vote Outperform)
Underperform Votes:  262 (Vote Underperform)
Total Votes:  592
MarketBeat's community ratings are surveys of what our community members think about Globus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Globus Medical (NYSE:GMED) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.582.582.452.30
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $46.29$40.57$35.00$29.50
Price Target Upside: 6.44% downside9.56% downside4.35% downside2.03% downside

Globus Medical (NYSE:GMED) Consensus Price Target History

Price Target History for Globus Medical (NYSE:GMED)

Globus Medical (NYSE:GMED) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/22/2018OppenheimerSet Price TargetHold$49.00MediumView Rating Details
2/22/2018Morgan StanleySet Price TargetOverweight -> Buy$48.00 -> $53.00MediumView Rating Details
2/22/2018Needham & Company LLCReiterated RatingHoldMediumView Rating Details
2/22/2018Canaccord GenuityReiterated RatingBuy -> Positive$47.00 -> $53.00MediumView Rating Details
2/22/2018BTIG ResearchBoost Price TargetOutperform -> Buy$51.00MediumView Rating Details
1/10/2018BarclaysReiterated RatingSell$36.00MediumView Rating Details
1/10/2018Wells Fargo & CoReiterated RatingOutperform$46.00 -> $51.00HighView Rating Details
11/14/2017GabelliReiterated RatingBuyN/AView Rating Details
11/10/2017Bank of AmericaUpgradeUnderperform -> NeutralN/AView Rating Details
10/19/2017Piper Jaffray CompaniesReiterated RatingBuyN/AView Rating Details
4/12/2017Leerink SwannUpgradeMarket Perform -> OutperformHighView Rating Details
2/28/2017AegisReiterated RatingBuy$31.00N/AView Rating Details
11/9/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016CitigroupDowngradeMarket Perform$29.00 -> $23.00N/AView Rating Details
11/9/2016JMP SecuritiesDowngradeOutperform -> Market PerformN/AView Rating Details
5/26/2016Goldman Sachs GroupDowngradeNeutral -> Sell$21.00N/AView Rating Details
5/4/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Globus Medical (NYSE:GMED) Earnings History and Estimates Chart

Earnings by Quarter for Globus Medical (NYSE:GMED)

Globus Medical (NYSE GMED) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$0.36N/AView Earnings Details
2/21/2018Q4 2017$0.35$0.38$175.50 million$176.03 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.30$0.30$150.73 million$151.74 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.30$0.32$150.94 million$152.39 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.31$0.32$155.81 millionViewListenView Earnings Details
2/27/2017Q416$0.33$0.31$149.30 million$151.59 millionViewListenView Earnings Details
11/8/2016Q3$0.28$0.29$139.25 million$135.70 millionViewListenView Earnings Details
7/26/2016Q2$0.29$0.29$141.78 million$137.49 millionViewListenView Earnings Details
5/3/2016Q1$0.28$0.29$140.30 million$139.30 millionViewListenView Earnings Details
2/24/2016Q4$0.30$0.32$141.20 million$142.60 millionViewListenView Earnings Details
11/3/2015Q3$0.25$0.28$127.46 million$137.00 millionViewListenView Earnings Details
7/30/2015Q215$0.25$0.25$126.89 million$133.60 millionViewListenView Earnings Details
5/5/2015Q115$0.24$0.26$122.30 million$131.60 millionViewListenView Earnings Details
2/25/2015Q414$0.25$0.30$127.77 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.21$0.24$113.10 million$117.80 millionViewListenView Earnings Details
8/5/2014Q214$0.23$0.23$119.83 million$113.60 millionViewListenView Earnings Details
4/29/2014Q114$0.22$0.24$113.59 million$114.20 millionViewListenView Earnings Details
2/26/2014Q413$0.22$0.25$114.96 million$115.20 millionViewListenView Earnings Details
10/30/2013Q313$0.19$0.22$106.00 million$107.19 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.20$0.21$107.46 million$107.00 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.20$0.21$103.14 million$105.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.19$0.22$99.13 million$100.50 millionViewListenView Earnings Details
11/1/2012Q312$0.19$0.18$95.32 million$94.76 millionViewN/AView Earnings Details
8/21/2012Q2 2012$0.25ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Globus Medical (NYSE:GMED) Earnings Estimates

2018 EPS Consensus Estimate: $1.53
2019 EPS Consensus Estimate: $1.68
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.36$0.37$0.37
Q2 20182$0.37$0.38$0.38
Q3 20182$0.36$0.37$0.37
Q4 20181$0.42$0.42$0.42
Q1 20191$0.41$0.41$0.41
Q2 20191$0.40$0.40$0.40
Q3 20191$0.40$0.40$0.40
Q4 20191$0.47$0.47$0.47
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Globus Medical (NYSE:GMED)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Globus Medical (NYSE GMED) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 28.21%
Institutional Ownership Percentage: 65.72%
Insider Trades by Quarter for Globus Medical (NYSE:GMED)
Institutional Ownership by Quarter for Globus Medical (NYSE:GMED)

Globus Medical (NYSE GMED) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2017Steven PayneCAOSell3,076$39.30$120,886.8023,847View SEC Filing  
12/13/2017Anthony L WilliamsPresidentSell15,000$38.30$574,500.0015,000View SEC Filing  
12/4/2017David D DavidarDirectorSell55,383$40.66$2,251,872.78752,236View SEC Filing  
11/9/2017A Brett MurphyInsiderSell51,449$35.00$1,800,715.0049,768View SEC Filing  
9/6/2017A Brett MurphyInsiderSell15,000$29.99$449,850.00101,217View SEC Filing  
6/5/2017Anthony L WilliamsPresidentSell16,153$31.94$515,926.8216,153View SEC Filing  
8/5/2016A Brett MurphyInsiderSell107,692$23.37$2,516,762.04190,917View SEC Filing  
1/6/2016Robert LiptakDirectorSell15,300$27.50$420,750.0026,159View SEC Filing  
1/4/2016Kurt WheelerDirectorSell255$27.50$7,012.5044,319View SEC Filing  
5/28/2015Steven PayneCAOSell3,076$25.92$79,729.92View SEC Filing  
3/19/2015David C PaulCEOSell1,922,000$25.00$48,050,000.00View SEC Filing  
1/15/2014David DemskiCOOSell96,813$20.51$1,985,634.63381,365View SEC Filing  
12/31/2013David DemskiCOOSell3,187$20.25$64,536.75478,178View SEC Filing  
12/20/2013David DemskiCOOSell50,000$19.75$987,500.00481,365View SEC Filing  
12/6/2013Robert LiptakDirectorSell25,000$19.36$484,000.0026,159View SEC Filing  
12/3/2013David DavidarVPSell75,000$19.25$1,443,750.00897,275View SEC Filing  
11/27/2013David DemskiCOOSell37,323$19.25$718,467.75531,365View SEC Filing  
11/1/2013David M DemskiCOOSell112,677$18.59$2,094,665.43View SEC Filing  
8/23/2013David DavidarVPSell7,278$18.20$132,459.60997,499View SEC Filing  
8/22/2013David DemskiCOOSell44,154$17.95$792,564.30681,365View SEC Filing  
7/5/2013David D DavidarVPSell10,000$17.15$171,500.00View SEC Filing  
7/1/2013David D DavidarVPSell20,000$16.56$331,200.00View SEC Filing  
6/26/2013David D DavidarVPSell150,000$16.71$2,506,500.00View SEC Filing  
8/8/2012David C PaulCEOSell3,039,385$11.16$33,919,536.60View SEC Filing  
8/8/2012David D DavidarVPSell166,885$11.16$1,862,436.60View SEC Filing  
8/8/2012David M DemskiCOOSell98,957$11.16$1,104,360.12View SEC Filing  
8/8/2012Kurt WheelerDirectorSell804,232$11.16$8,975,229.12View SEC Filing  
8/8/2012Steven PayneCAOSell2,305$11.16$25,723.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Globus Medical (NYSE GMED) News Headlines

Source:
DateHeadline
Globus Medical Inc (GMED) to Post Q4 2018 Earnings of $0.42 Per Share, William Blair ForecastsGlobus Medical Inc (GMED) to Post Q4 2018 Earnings of $0.42 Per Share, William Blair Forecasts
www.americanbankingnews.com - February 23 at 2:18 PM
Globus Medical (GMED) PT Raised to $51.00Globus Medical (GMED) PT Raised to $51.00
www.americanbankingnews.com - February 22 at 11:32 PM
Globus Medicals (GMED) Positive Rating Reiterated at Canaccord GenuityGlobus Medical's (GMED) Positive Rating Reiterated at Canaccord Genuity
www.americanbankingnews.com - February 22 at 10:58 PM
Globus Medicals (GMED) Hold Rating Reaffirmed at Needham & Company LLCGlobus Medical's (GMED) Hold Rating Reaffirmed at Needham & Company LLC
www.americanbankingnews.com - February 22 at 10:58 PM
Globus Medical (GMED) Given a $53.00 Price Target by Morgan Stanley AnalystsGlobus Medical (GMED) Given a $53.00 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - February 22 at 7:58 PM
Globus Medical (GMED) Given a $49.00 Price Target by Oppenheimer AnalystsGlobus Medical (GMED) Given a $49.00 Price Target by Oppenheimer Analysts
www.americanbankingnews.com - February 22 at 1:34 PM
Globus Medical (GMED) Announces Quarterly  Earnings Results, Beats Expectations By $0.03 EPSGlobus Medical (GMED) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - February 22 at 12:54 PM
Globus Medical tops Street 4Q forecastsGlobus Medical tops Street 4Q forecasts
finance.yahoo.com - February 22 at 9:15 AM
Globus Medical Inc. 4th Quarter: The Rise of the RobotGlobus Medical Inc. 4th Quarter: The Rise of the Robot
finance.yahoo.com - February 22 at 9:15 AM
Globus Medical (GMED) Issues FY18 Earnings GuidanceGlobus Medical (GMED) Issues FY18 Earnings Guidance
www.americanbankingnews.com - February 21 at 6:08 PM
Why Globus Medical Inc (NYSE:GMED) Could Be A BuyWhy Globus Medical Inc (NYSE:GMED) Could Be A Buy
finance.yahoo.com - February 21 at 4:43 PM
Globus Medical Q4 Earnings PreviewGlobus Medical Q4 Earnings Preview
finance.yahoo.com - February 21 at 4:43 PM
Globus Medical Reports Full Year and Fourth Quarter 2017 ResultsGlobus Medical Reports Full Year and Fourth Quarter 2017 Results
finance.yahoo.com - February 21 at 4:43 PM
Zacks: Brokerages Expect Globus Medical Inc (GMED) to Announce $0.35 EPSZacks: Brokerages Expect Globus Medical Inc (GMED) to Announce $0.35 EPS
www.americanbankingnews.com - February 20 at 1:22 AM
Did Globus Medical Inc (NYSE:GMED) Create Value For Investors Over The Past Year?Did Globus Medical Inc (NYSE:GMED) Create Value For Investors Over The Past Year?
finance.yahoo.com - February 19 at 4:30 PM
Globus Medical (GMED) Set to Announce Quarterly Earnings on MondayGlobus Medical (GMED) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - February 19 at 4:30 AM
Globus Medical Inc (GMED) Given Consensus Recommendation of "Buy" by BrokeragesGlobus Medical Inc (GMED) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 13 at 3:30 AM
Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference CallGlobus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call
finance.yahoo.com - February 9 at 9:14 AM
Globus Medical Inc (GMED) Expected to Post Quarterly Sales of $175.50 MillionGlobus Medical Inc (GMED) Expected to Post Quarterly Sales of $175.50 Million
www.americanbankingnews.com - February 5 at 6:58 AM
Zacks: Brokerages Expect Globus Medical Inc (GMED) Will Post Earnings of $0.35 Per ShareZacks: Brokerages Expect Globus Medical Inc (GMED) Will Post Earnings of $0.35 Per Share
www.americanbankingnews.com - February 3 at 3:12 AM
Globus Medical Inc (GMED) Receives Average Recommendation of "Buy" from BrokeragesGlobus Medical Inc (GMED) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 19 at 3:58 AM
$0.34 EPS Expected for Globus Medical Inc (GMED) This Quarter$0.34 EPS Expected for Globus Medical Inc (GMED) This Quarter
www.americanbankingnews.com - January 17 at 3:10 AM
Equities Analysts Issue Forecasts for Globus Medical Incs FY2017 Earnings (GMED)Equities Analysts Issue Forecasts for Globus Medical Inc's FY2017 Earnings (GMED)
www.americanbankingnews.com - January 15 at 2:38 AM
Q4 2018 Earnings Forecast for Globus Medical Inc (GMED) Issued By William BlairQ4 2018 Earnings Forecast for Globus Medical Inc (GMED) Issued By William Blair
www.americanbankingnews.com - January 12 at 8:02 PM
FY2017 EPS Estimates for Globus Medical Inc (GMED) Lifted by William BlairFY2017 EPS Estimates for Globus Medical Inc (GMED) Lifted by William Blair
www.americanbankingnews.com - January 11 at 8:04 AM
Globus Medical (GMED) Upgraded to Hold at Zacks Investment ResearchGlobus Medical (GMED) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - January 11 at 12:10 AM
Globus Medical (GMED) Receives "Sell" Rating from BarclaysGlobus Medical (GMED) Receives "Sell" Rating from Barclays
www.americanbankingnews.com - January 10 at 12:50 PM
Globus Medicals (GMED) Outperform Rating Reiterated at Wells Fargo & CoGlobus Medical's (GMED) Outperform Rating Reiterated at Wells Fargo & Co
www.americanbankingnews.com - January 10 at 8:20 AM
Globus Medical (GMED) Updates FY18 Earnings GuidanceGlobus Medical (GMED) Updates FY18 Earnings Guidance
www.americanbankingnews.com - January 9 at 9:12 AM
Globus Medical (GMED) Stock Rating Lowered by Zacks Investment ResearchGlobus Medical (GMED) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 4 at 11:52 PM
Medical Equipment Stocks Research Reports Released on Medtronic, Edwards Lifesciences, Globus Medical, and ... - PR Newswire (press release)Medical Equipment Stocks' Research Reports Released on Medtronic, Edwards Lifesciences, Globus Medical, and ... - PR Newswire (press release)
www.prnewswire.com - January 4 at 9:21 AM
Morgan Stanley Upgrades Globus Medical, Expects 17% Upside - BenzingaMorgan Stanley Upgrades Globus Medical, Expects 17% Upside - Benzinga
www.benzinga.com - January 4 at 9:21 AM
Globus Medical (GMED) Given a $45.00 Price Target at BTIG ResearchGlobus Medical (GMED) Given a $45.00 Price Target at BTIG Research
www.americanbankingnews.com - January 2 at 8:04 AM
Head-To-Head Contrast: Halyard Health (HYH) & Globus Medical (GMED)Head-To-Head Contrast: Halyard Health (HYH) & Globus Medical (GMED)
www.americanbankingnews.com - December 31 at 11:14 PM
$0.34 Earnings Per Share Expected for Globus Medical Inc (GMED) This Quarter$0.34 Earnings Per Share Expected for Globus Medical Inc (GMED) This Quarter
www.americanbankingnews.com - December 31 at 11:26 AM
Why Globus Medical Should Be on Your Watch ListWhy Globus Medical Should Be on Your Watch List
www.fool.com - December 30 at 1:07 AM
ETFs with exposure to Globus Medical, Inc. : December 27, 2017ETFs with exposure to Globus Medical, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 1:49 PM
Globus Medical, Inc. :GMED-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017Globus Medical, Inc. :GMED-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 2:33 PM
Financial Comparison: Antares Pharma (ATRS) vs. Globus Medical (GMED)Financial Comparison: Antares Pharma (ATRS) vs. Globus Medical (GMED)
www.americanbankingnews.com - December 25 at 11:06 AM
Globus Medical Inc (GMED) Receives Average Rating of "Hold" from AnalystsGlobus Medical Inc (GMED) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 25 at 3:57 AM
First Week of GMED February 2018 Options TradingFirst Week of GMED February 2018 Options Trading
www.nasdaq.com - December 20 at 9:23 AM
Insider Selling: Globus Medical Inc (GMED) CAO Sells 3,076 Shares of StockInsider Selling: Globus Medical Inc (GMED) CAO Sells 3,076 Shares of Stock
www.americanbankingnews.com - December 18 at 6:20 PM
$165.40 Million in Sales Expected for Globus Medical Inc (GMED) This Quarter$165.40 Million in Sales Expected for Globus Medical Inc (GMED) This Quarter
www.americanbankingnews.com - December 16 at 9:56 AM
Globus Medical Inc (GMED) President Sells $574,500.00 in StockGlobus Medical Inc (GMED) President Sells $574,500.00 in Stock
www.americanbankingnews.com - December 14 at 5:34 PM
Globus Medical Inc (GMED) Expected to Announce Earnings of $0.34 Per ShareGlobus Medical Inc (GMED) Expected to Announce Earnings of $0.34 Per Share
www.americanbankingnews.com - December 14 at 9:50 AM
Globus Medical Inc Forecasted to Earn FY2020 Earnings of $1.65 Per Share (GMED)Globus Medical Inc Forecasted to Earn FY2020 Earnings of $1.65 Per Share (GMED)
www.americanbankingnews.com - December 14 at 12:50 AM
Globus Medical Inc (GMED) Forecasted to Post FY2019 Earnings of $1.50 Per ShareGlobus Medical Inc (GMED) Forecasted to Post FY2019 Earnings of $1.50 Per Share
www.americanbankingnews.com - December 13 at 11:28 PM
Head-To-Head Contrast: Baxter International (BAX) vs. Globus Medical (GMED)Head-To-Head Contrast: Baxter International (BAX) vs. Globus Medical (GMED)
www.americanbankingnews.com - December 10 at 5:22 AM
Head-To-Head Contrast: Globus Medical (GMED) and Its PeersHead-To-Head Contrast: Globus Medical (GMED) and Its Peers
www.americanbankingnews.com - December 9 at 5:30 AM
Analyzing Globus Medical (GMED) & Its RivalsAnalyzing Globus Medical (GMED) & Its Rivals
www.americanbankingnews.com - December 7 at 11:34 PM

SEC Filings

Globus Medical (NYSE:GMED) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Globus Medical (NYSE:GMED) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Globus Medical (NYSE GMED) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.